Eligibility of Pfizer-BioNTech COVID-19 Booster Dose Expanded to 16 Years of Age and Older

December 15, 2021

Effective December 9, 2021, the U.S Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) vaccine, to allow administration of a single booster dose for administration to individuals 16 years of age or older at least six months after completion of primary vaccination with the Pfizer-BioNTech COVID-19 vaccine.

For the most current direction regarding billing guidelines for this expanded population, refer to the Pfizer-BioNTech COVID-19 Vaccine pages of the Medi-Cal Providers website.

Providers with questions should contact the Telephone Service Center (TSC) Help Desk at 1-800-541-5555, 8 a.m. to 5 p.m., Monday through Friday, except holidays. Border providers and out-of-state billers billing for in-state providers should call 1-916-636-1200.